A new study found that Novo Nordisk’s nearly $1,000 per month diabetes medication Ozempic can be produced for less than $5 a month. Novo Nordisk and Johnson & Johnson both announced billion-dollar deals to acquire heart treatments. And Moderna teases its future beyond COVID-19 vaccines.